1
974
W. Zhang et al.
(
H, brs, H-1), 1.75 (H, m, H-2), 2.04 (H, m, H-2), 3.93 (H, m, H-3), 2.34 (H, m, H-4), 2.37 (H, m, H-
4
), 5.74 (H, d, J ¼ 4.5 Hz, H-6), 3.74 (H, t, J ¼ 4.5 Hz, 7.5 Hz, H-7), 1.94 (H, m, H-9), 1.52 (H, m,
H-11), 1.58 (H, m, H-11), 1.25 (H, m, H-12), 2.06 (H, m, H-12), 1.84 (H, m, H-16), 1.22 (H, m,
H-16), 1.24 (H, m, H-17), 0.78 (3H, s, H-18), 1.02 (3H, s, H-19), 2.18 (H, m, H-20), 1.04 (3H, d,
J ¼ 6.5 Hz, H-21), 3.91 (H, br dt, J ¼ 9.0 Hz, 3.5 Hz, H-22), 2.02 (H, m, H-23), 2.48 (H, dd,
J ¼ 11.0 Hz, 18.0 Hz, H-23), 4.13(H, d, J ¼ 10.5 Hz, H-26), 4.42 (H, d, J ¼ 10.5 Hz, H-26), 1.86
0
00
(
3H, s, H-27), 1.84 (3H, s, H-28), 4.26 (H, d, J ¼ 7.5 Hz, H-1 -Glc), 4.29 (H, d, J ¼ 7.5 Hz, H-1 ’-
3
1
Glc). C NMR (500 MHz, CD OD): d 73.6 (C-1), 39.1 (C-2), 66.7 (C-3), 42.4 (C-4), 144.3 (C-5),
3
1
5
27.4 (C-6), 66.0 (C-7), 39.0 (C-8), 35.1 (C-9), 43.3 (C-10), 21.0 (C-11), 40.6 (C-12), 43.7 (C-13),
0.7 (C-14), 28.7 (C-15), 25.3 (C-16), 54.4 (C-17), 12.1 (C-18), 18.9 (C-19), 42.1 (C-20), 13.5
(
(
(
C-21), 83.2 (C-22), 34.5 (C-23), 128.1 (C-24), 134.6 (C-25), 71.3 (C-26), 19.3 (C-27), 18.2
0
0
0
0
0
0
C-28), 105.7 (C-1 , 22-O-Glc), 75.9 (C-2 ), 77.9 (C-3 ), 71.8 (C-4 ), 78.0 (C-5 ), 62.9 (C-6 ), 103.3
00
0
0
00
00
00
00
C-1 , 26-O-Glc), 75.1 (C-2 ), 78.0 (C-3 ), 71.8 (C-4 ), 78.0 (C-5 ), 62.9 (C-6 ).
3
.5.1 Acid hydrolysis of 1
Compound 1 (2.0 mg) was treated in 1 M H SO (dioxane: H O, 1:1, 2 mL) at 1008C for 2 h. The
2
4
2
acid aqueous layer was neutralised with BaCl to give a BaSO precipitate. After filtering,
2
4
the aqueous was concentrated under reduce pressure to dryness. TLC analysis compared with the
authentic glucose (n-BuOH–HOAc–H O, 4:1:5, v/v/v, upper layer) and optical rotation
2
2
5
dispersion ½aꢀD þ 52.6 (c 0.03, H O) indicated the presence of D-glucose.
2
Supplementary material
Supplementary material relating to this article is available online, alongside Figures S1–S8.
Acknowledgements
We acknowledge the financial support by the National Natural Science Foundation of China (No.
8
1073009) and the Fund of the Scientific Innovation Program of Postgraduates in Jiangsu Province. The
project was also funded by the Priority Academic Program Development of Jiangsu Higher Education
Institutions.
References
Chinese Pharmacopoeia Commission. 2010. Chinese pharmacopoeia. Vol. 1. Beijing: Chemical Industry Press, p. 41.
Li J, Shi J, Yu XW, Sun JK. 2011. Chemical and pharmacological researches on Hyoscyamus niger. Chin Herb Med.
3:117–126.
Lu YY, Luo JG, Huang XF, Kong LY. 2009. Four new steroidal glycosides from Solanum torvum and their cytotoxic
activities. Steroids. 74:95–101.
Lu YY, Luo JG, Kong LY. 2011. Steroidal alkaloid saponins and steroidal saponins from Solanum surattense.
Phytochemistry. 72:668–673.
Lunga I, Bassarello C, Kintia P, Shvets S, Piacente S, Pizza C. 2008a. Steroidal saponins from the seeds of Hyoscyamus
niger L. Nat Prod Commun. 3:731–734.
Lunga I, Kintia P, Shvets S, Bassarello C, Piacente S. 2008b. Steroidal saponins from the seeds of Hyoscyamus niger L.
Chem J Moldova. Gen Ind Ecol Chem. 3:89–93.
Ma CY, Liu WK, Che CT. 2002. Lignanamides and nonalkaloidal components of Hyoscyamus niger seeds. J Nat Prod.
65:206–209.
Waiss AC, Jr, Elliger CA, Haddon WF, Benson M. 1993. Insect inhibitory steroidal saccharide esters from Physalis
peruviana. J Nat Prod. 56:1365–1372.
Zhu XH, Ando J, Takagi M. 2001. Six new with anolide-type steroids from the leaves of Solanum cilistum. Chem Pharm
Bull. 49:161–165.
Zhang WN, Luo JG, Kong LY. 2012. Phytotoxicity of lignanamides isolated from the seeds of Hyoscyamus niger. J Agric
Food Chem. 60:1682–1687.